Today in "Small Cap Friday" I am taking a look at a small biopharma concern that has taken some lumps recently, but whose long-term prospects still look brightThanks to the deep decline in the biotech and biopharma sectors, the same could be said about myriad names in the industry right now. The company profiled below is going through a transitio...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.